J. Li, T. Srivastava, R. Rawal, E. Manuel, D. Isbell, W. Tsark, C. La Rosa, Z. Wang, Z. Li, P. A. Barry, K. Hagen, J. Longmate, D. J. Diamond. Mamu-A*01/Kb transgenic and MHC Class I knockout mice as a tool for HIV vaccine development. Virology, 2009; 387, 16-28.
A. Krishnan, W. Zhou, S. F. Lacey, A. P. Limaye, D. J. Diamond, C. La Rosa. PD-1 and IL-10 monitoring to identify liver transplant recipients at high risk for late CMV disease. Transplantation Infectious Disease, 2009, in press.
E. Manuel, Z. Wang, W. Zhou, T. Srivastava, C. La Rosa, D. J. Diamond. Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines. Vaccine, 2009 in press.
A. Krishnan, Z. Wang, T. Srivastava, R. Rawal, P. Manchanda, D. J. Diamond, C. La Rosa. A novel approach to evaluate the immunogenicity of viral antigens of clinical importance in HLA transgenic murine models. Immunology Letters, 2008, 120, 108-116.
Z. Wang, W. Zhou, T. Srivastava, C. La Rosa, A. Mandarino, S. J. Forman, J. A. Zaia, W. J. Britt, D. J. Diamond. A fusion protein of HCMV IE1 exon4 and IE2 exon5 stimulates potent cellular immunity in an MVA Vaccine Vector. Virology, 2008, 377, 379-390.
C. La Rosa, A. Krishnan, J. Longmate, J. Martinez, P. Manchanda, S. F. Lacey A. P. Limaye, D. J. Diamond. PD-1 expression in liver transplant recipients as a prognostic indicator of CMV disease. Journal of Infectious Diseases, 2008, 197, 25-33.
C. La Rosa, A. P. Limaye, A. Krishnan, J. Longmate, D. J. Diamond. Longitudinal assessment of CMV-specific immune responses in liver transplant recipients at high risk for late CMV disease. Journal of Infectious Diseases, 2007, 195, 633-644.
Z. Wang, C. La Rosa, L. Zhongqi, H. Ly, A. Krishnan, J. Martinez, W. J. Britt, D. J. Diamond. Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1. Vaccine, 2007, 25, 1132.
S. F. Lacey, C. La Rosa, W. Zhou, M. C. Sharma, J. Martinez, A. Krishnan, G. Gallez-Hawkins, L. Thao, J. Longmate, R. Spielberger, S. J. Forman, A. Limaye, J. A. Zaia, D. J. Diamond. Functional comparison of T-cells recognizing CMV pp65 and IE1 polypeptides in HSCT and SOT recipients. Journal of Infectious Diseases, 2006, 194, 1410-1421.
C. La Rosa, Z. Wang, S. F. Lacey, M. M. Lalimarmo, A. Krishnan, J. Longmate, D. J. Diamond. In vitro expansion of polyclonal T cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara. Experimental Hematology, 2006, 34, 497-507.
Z. Wang, C. La Rosa, S. F. Lacey, R. Maas, S. Mekhoubad, J. Longmate, W. J. Britt, D. J. Diamond. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection. Journal of Clinical Virology, 2006, 35, 324-331.
C. La Rosa, Z. Wang, S. F. Lacey, S. F. Markel, M. C. Sharma, J. Martinez, M. M. Lalimarmo, D. J. Diamond. Characterization of host immunity to CMV-pp150 (UL32). Human Immunology, 2005, 66, 115-125.
C. La Rosa, Z. Wang, S. Mekhoubad, S. F. Lacey, M. C. Villacres, S. Markel, J. Longmate, J. D. I. Ellenhorn, R. F. Siliciano, C. Buck, W. J. Britt, D. J. Diamond. Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells. Blood, 2004, 104, 847-856.
Z. Wang, C. La Rosa, R. Maas, H. Ly, J. Brewer, S. Mekhoubad, P. Daftarian, J. Longmate, W. J. Britt, D. J. Diamond. Recombinant Modified Vaccinia Virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus. Journal of Virology, 2004, 78, 3965-3976.
C. La Rosa, Z. Wang, J. C. Brewer, S. F. Lacey, M. Villacres, R. Sharan, R. Krishnan, M. Crooks, S. Markel, R. Maas, D. J. Diamond. Pre-clinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice. Blood, 2002, 10, 3681-3689.
C. La Rosa, R. Krishnan, S. Markel, J. P. Schneck, R. Houghten, C. Pinilla, D. J. Diamond. Enhanced immune activity of cytotoxic T-lymphocyte epitope analogues derived from positional scanning synthetic combinatorial libraries. Blood, 2001, 97, 1776-1786.
S. Lombardi, C. Garzelli, C. La Rosa, L. Zaccaro, S. Specter, G. Malvaldi, F. Tozzini, F. Esposito, M. Bendinelli. Identification of a linear neutralization site within the third variable region of feline immunodeficiency virus envelope. Journal of Virology, 1993, 67, 4742-4749.
F. Esposito, S. Lombardi, D. Modiano, A. Habluetzel, L. Del Nero, L. Lamizana, V. Pietra, G. Rotigliano, G. Corradin, E. Ravot, C. La Rosa. In vitro immune recognition of synthetic peptides from the Plasmodium falciparum CS protein by individuals naturally exposed to different sporozoite challenge. Immunology Letters, 1992, 33, 187-200.
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 12/09.
